Hjartarson Hjörtur F, Toksvig-Larsen Sören
Dept of Orthopedics, Landspitali University Hospital, E-4 Fossvogur, 101, Reykjavik, Iceland.
Lund University, Lund, Sweden.
BMC Musculoskelet Disord. 2018 Sep 22;19(1):341. doi: 10.1186/s12891-018-2256-7.
Treatment of patients with knee osteoarthritis is challenging. Unloader braces have been developed with various success. Unloader One® Knee Brace is light, easily-fitted and shown to be effective by the unloading of the affected compartment. The aim of the study was to assess the clinical outcome of the brace vs. a placebo on patients with knee osteoarthritis.
Initially 150 patients were randomized to receive either the Unloader brace or a control placebo group look-alike brace where the active strips had been removed. The patients were followed up at 6,12,26 and 52 weeks with Knee Society Score (KSS) and Knee injury and Osteoarthritis Outcome Score (KOOS). The reason for dropout was recorded.
A total of 149 patients were included, 74 in the study and 75 in the control group. The mean age was 59.6 vs. 60.2, BMI was 27.5 vs. 26.9, 37% vs. 44% were women in the study vs. control group. Both groups showed improvement in KSS over 52 weeks, with the study group showing higher improvement in mean scores. KSS increased from 64.3 to 84.0 for the study group and from 64.0 to 74.6 for the control group (p = 0.009). The study group improved in KSS function from 67.0 to 78.6 (p < 0.001) and KOOS for knee related symptoms increased/improved from 64.3 to 72.4 (p < 0.001). Activity of daily living increased/improved from 65.3 to 75.2 and Sports/Recreation from 24.6 to 40.2 (p > 0.001) whereas the control group did not show significant improvements in any of the scores. The dropout was higher in the control group, 40 vs. 25.
The brace seems to be more effective and better tolerated than the placebo.
The trial was retrospectively registered with ClinicalTrials.gov ( NCT03454776 ) on March 6th 2018.
膝关节骨关节炎患者的治疗具有挑战性。已开发出多种卸载支具,且取得了不同程度的成功。Unloader One®膝关节支具轻便、易于佩戴,并且通过卸载患侧关节间室已被证明是有效的。本研究的目的是评估该支具与安慰剂相比对膝关节骨关节炎患者的临床疗效。
最初,150名患者被随机分为两组,分别接受Unloader支具或对照安慰剂组外观相似的支具(已去除活性条带)。在6周、12周、26周和52周时,采用膝关节协会评分(KSS)和膝关节损伤与骨关节炎疗效评分(KOOS)对患者进行随访。记录退出研究的原因。
共纳入149名患者,研究组74名,对照组75名。研究组与对照组的平均年龄分别为59.6岁和60.2岁,体重指数分别为27.5和26.9,女性比例分别为37%和44%。两组在52周内KSS均有改善,研究组平均得分改善更高。研究组KSS从64.3提高到84.0,对照组从64.0提高到74.6(p = 0.009)。研究组KSS功能从67.0提高到78.6(p < 0.001),KOOS膝关节相关症状从64.3提高到72.4(p < 0.001)。日常生活活动能力从65.3提高到75.2,运动/娱乐能力从24.6提高到40.2(p > 0.001),而对照组在任何一项评分中均未显示出显著改善。对照组退出率更高,为40人,而研究组为25人。
该支具似乎比安慰剂更有效且耐受性更好。
该试验于2018年3月6日在ClinicalTrials.gov(NCT03454776)进行回顾性注册。